Archived 39: Summary of NACI statement of September 1, 2022: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines

ASEM 文献综述

Official National Advisory Committee on Immunization document (2022) on “Archived 39: Summary of NACI statement of September 1, 2022: Recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines”. What you need to know: NACI summary of recommendations on the use of bivalent Omicron-containing mRNA COVID-19 vaccines.

此摘要有助于您识别文档。对于临床建议，请始终查阅官方现行版本及其更新日期。